Life Sciences Industry News

Milken Institute Ranks Utah Sixth in Nation for Innovation Capacity

The Milken Institute 2020 State Technology and Science Index ranks Utah #6 in the nation for its knowledge…
Quansys Biosciences Receives EUA for COVID-19 Antibody Test, Provides Exceptional Clinical Performance

Quansys Biosciences has received emergency use authorization (EUA) from the FDA for its COVID-19 antibody test. The test…
SDP Oncology Announces First Patient Dosed in a Phase 1 Solid Tumor Study

Lehi-based Sumitomo Dainippon Pharma Oncology (SDP Oncology) recently announced that the first patient has been dosed with the…
BioHive Launched at Utah Life Sciences Summit – Join the Campaign

The 11th annual Utah Life Sciences Summit (ULSS) Nov. 9-11, went virtual this year. But despite the…
Transit Scientifc’s New Angioplasty System Dilates Calcified & Fibrotic Vessels

Transit Scientific’s new FDA cleared XO Score system was successfully used to dilate multiple challenging fibrotic and calcific…
BioUtah Launches BioHive Initiative to Promote Utah’s Life Sciences Industry

Article courtesy of BusinessWire Local leaders to create ecosystem for innovation, job creation, and growth SALT LAKE CITY–(BUSINESS…
Dr. Dinesh C. Patel Honored with Utah Governor’s Lifetime Achievement Medal

Utah’s own life sciences entrepreneur, Dinesh C. Patel, PhD, has been honored with the Utah Governor’s Lifetime Achievement…
Sanofi Commits $1M to Support Parkinson’s Disease Genetic Research

Sanofi and the Parkinson’s Foundation announced on Wednesday a new research collaboration to advance the availability of genetic…
IDbyDNA and Illumina Launch New Rapid Test to Better Detect COVID-19, Flu, Respiratory Co-Infections

Utah-based IDbyDNA announced yesterday that, in an effort to help labs better identify respiratory pathogens and avoid overuse…
SDP Oncology Announces First Patient Dosed in a Phase 1 Solid Tumor Study

Lehi-based Sumitomo Dainippon Pharma Oncology (SDP Oncology) recently announced that the first patient has been dosed with the…
Sumitomo Dainippon Pharma Oncology Announces First Patient Dosed with TP-1454 in Patients with Advanced Solid Tumors

CAMBRIDGE, Mass., October 9, 2020 – Sumitomo Dainippon Pharma Oncology, Inc., a developer of novel cancer therapeutics, today…
Mountain Pacific Venture Fund Invests in SLC Laparoscopic Device Company Xenocor

Utah-based Mountain Pacific Venture Fund (MPVF) announced on Monday an investment in Xenocor, a Salt Lake City-based medical…